vigilance and Benefit-Risk Management Executive Directorate is concerned with detection, assessment and prevention of adverse drug reaction "ADR".

 Objectives of the center

1- Early detection of adverse drug reactions.

2- Detection of increase in frequency of (known) adverse reaction.

3- Identification of risk factors and possible mechanisms underlying adverse reactions.

4- Estimation of quantitative aspects of benefit/risk analysis and dissemination of information needed to improve drug prescribing and regulation.

5- Prevention of adverse drug reactions.

6- Drug quality surveillance.

7- Encouraging rational and safe use of drugs.

8- Communication with international institutions working in pharmacovigilance.

 
​​​